
Generic: the unbranding of modern medicine
- 서명/저자사항
- Generic: the unbranding of modern medicine
- 개인저자
- Greene, Jeremy A. 1974-
- 발행사항
- Baltimore : Johns Hopkins University Press, 2014.
- 형태사항
- xii, 354 p. : ill. ; 24 cm.
- ISBN
- 1421414937 (hardcover : alk. paper) 9781421414935 (hardcover : alk. paper):##
- 주기사항
- Includes bibliographical references and index Ordering the world of cures -- The generic as critique of the brand -- Drugs anonymous -- Origins of a self-effacing industry -- Generic specificity -- Contests of equivalence -- The significance of differences -- Substitution as vice and virtue -- Universal exchange -- Liberating the captive consumer -- Generic consumption in the clinic, pharmacy, and supermarket -- Science and politics of the 'me-too' drug -- Preferred drugs, public and private -- The global generic
소장정보
위치 | 등록번호 | 청구기호 / 출력 | 상태 | 반납예정일 |
---|---|---|---|---|
이용 가능 (1) | ||||
자료실 | WM019865 | 대출가능 | - |
- 등록번호
- WM019865
- 상태/반납예정일
- 대출가능
- -
- 위치/청구기호(출력)
- 자료실
책 소개
The turbulent history of generic pharmaceuticals raises powerful questions about similarity and difference in modern medicine.
Generic drugs are now familiar objects in clinics, drugstores, and households around the world. We like to think of these tablets, capsules, patches, and ointments as interchangeable with their brand-name counterparts: why pay more for the same? And yet they are not quite the same. They differ in price, in place of origin, in color, shape, and size, in the dyes, binders, fillers, and coatings used, and in a host of other ways. Claims of generic equivalence, as physician-historian Jeremy Greene reveals in this gripping narrative, are never based on being identical to the original drug in all respects, but in being the same in all ways that matter.
How do we know what parts of a pill really matter? Decisions about which differences are significant and which are trivial in the world of therapeutics are not resolved by simple chemical or biological assays alone. As Greene reveals in this fascinating account, questions of therapeutic similarity and difference are also always questions of pharmacology and physiology, of economics and politics, of morality and belief.
Generic is the first book to chronicle the social, political, and cultural history of generic drugs in America. It narrates the evolution of the generic drug industry from a set of mid-twentieth-century "schlock houses" and "counterfeiters" into an agile and surprisingly powerful set of multinational corporations in the early twenty-first century.
The substitution of bioequivalent generic drugs for more expensive brand-name products is a rare success story in a field of failed attempts to deliver equivalent value in health care for a lower price. Greene’s history sheds light on the controversies shadowing the success of generics: problems with the generalizability of medical knowledge, the fragile role of science in public policy, and the increasing role of industry, marketing, and consumer logics in late-twentieth-century and early twenty-first century health care.